Directors' Dealings with financial instruments of the company
Disclosures concerning own-account transactions by persons discharging managerial responsibilities pursuant to Section 19 Market Abuse Regulation (Directors' Dealings)
Members of the Supervisory Board and the Executive Board and other persons discharging managerial responsibilities who regularly have access to insider information on the Company and who are authorized to make significant business decisions, and certain persons who are in a close relationship with those persons, are, pursuant to Section 19 of the Regulation (EU) No. 596/2014 from April 16, 2016 on market abuse (Market Abuse Regulation),legally obligated to immediately disclose to Bilfinger SE and the German Financial Supervision Authority (BaFin) any dealing on their own account of shares, debt securities of Bilfinger SE or associated derivatives or any other related financial instruments in an amount of more than €5,000 in any calendar year within 3 business days following the date of the transaction at the latest. Details of such transactions will be published without delay.
Members of the Executive Board and the Supervisory Board do not own any shares in the Company or any related financial instruments that together, either directly or indirectly, constitute more than 1 percent of the shares issued by the Company.
- Purchase Dr. Klaus Patzak, 14.12.2016 [pdf, 183.6 KB]
- Purchase Dr. Klaus Patzak, 12.12.2016 [pdf, 183.3 KB]
- Purchase Michael Bernhardt, 25.11.2016 [pdf, 183.3 KB]
- Purchase Tom Blades, 23.11.2016 [pdf, 184.7 KB]
- Purchase Dr. Klaus Patzak, 17.11.2016 [pdf, 183.8 KB]
- Purchase Tom Blades, 14.11.2016 [pdf, 184.8 KB]